Oncology Clinical Trials in Commack, NY

As of July 2026, 175 paid clinical trials are recruiting for Oncology in Commack, New York. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

181 clinical trials for Oncology

·Clear filters·↓ Download CSV

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

for Lymphedema

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18 - 75

Code: NCT06144164·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

for Lung Cancer

Drug: Nivolumab

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT04991025·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

for Breast Cancer

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18 - 44·Accepts healthy volunteers

Code: NCT00823654·Recruiting·Listed Jan 2009

Apply to this trial

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

for Malignant Peritoneal Mesothelioma

Sites in Commack, Uniondale +11 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06057935·Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

for Invasive Ductal Breast Carcinoma

Sites in Commack, Uniondale +7 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 45+

Code: NCT04084730·Phase 2·Recruiting·Listed Sep 2019

Apply to this trial

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

for Lung Cancer

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06863233·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

for Breast Cancer

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18+

Code: NCT03351348·Phase 3·Recruiting·Listed Nov 2017

Apply to this trial

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

for Breast Cancer

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18+

Code: NCT05590949·Recruiting·Listed Oct 2022

Apply to this trial

Using Urine Samples to Identify Lung Cancer

for Non Small Cell Lung Cancer

Sites in Commack, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18 - 90·Accepts healthy volunteers

Code: NCT06033248·Recruiting·Listed Sep 2023

Apply to this trial

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

for Head and Neck Cancer

Drug: Cemiplimab

Sites in Commack, Rockville Centre +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT04722523·Phase 1·Recruiting·Listed Jan 2021

Apply to this trial

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

for Sarcoma

Sites in Commack, Rockville Centre +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: All ages

Code: NCT00579566·Recruiting·Listed Dec 2007

Apply to this trial

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for Prostate Cancer

Sites in Commack +4 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07192614·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

for Breast Cancer

Sites in Commack +9 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT05123482·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for Endometrial Cancer

Sites in Commack +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for Gastric Cancer

Sites in Commack +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06219941·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Conditions in Oncology (Commack, NY)

Breast cancer· 28 Non-small cell lung cancer (NSCLC)· 19 Multiple myeloma· 14 Acute myeloid leukemia (AML)· 12 Prostate cancer· 11 Metastatic breast cancer· 10 Endometrial cancer· 10 Bladder cancer· 9 Ovarian cancer· 9 Solid tumor· 8 Colorectal cancer· 7 Pancreatic cancer· 7 Kidney cancer· 7 Non-Hodgkin lymphoma· 7 Sarcoma· 7 Lung cancer· 6 Gastric cancer· 6 Glioma· 5 Head and neck cancer· 5 Cancer (any)· 5 Rectal cancer· 4 Melanoma· 4 Triple-negative breast cancer· 3 Leukemia (other)· 3 HER2-positive breast cancer· 2 HER2-negative breast cancer· 2 Esophageal cancer· 2 Biliary tract cancer· 2 Gastrointestinal cancer· 2 Metastatic prostate cancer· 2 Cervical cancer· 2 Fallopian tube cancer· 2 Acute lymphoblastic leukemia· 2 Myelodysplastic syndromes (MDS)· 2 Hodgkin lymphoma· 2 Diffuse large B-cell lymphoma (DLBCL)· 2 Follicular lymphoma· 2 Hematologic malignancy· 2 Thyroid cancer· 2 Mesothelioma· 2 Colon cancer· 1 Gastroesophageal junction cancer· 1 Gynecologic cancer· 1 Glioblastoma· 1 Brain cancer· 1 Brain metastases· 1 Chronic lymphocytic leukemia (CLL)· 1 Myelofibrosis· 1 Marginal zone lymphoma· 1 Small lymphocytic lymphoma· 1 Soft tissue sarcoma· 1 Osteosarcoma· 1 Neuroblastoma· 1